APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade

Total Page:16

File Type:pdf, Size:1020Kb

APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade pharmaceuticals Article APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade Debolina Ganguly 1, Chun Cai 1, Michelle M. Sims 1, Chuan He Yang 1, Matthew Thomas 1, Jinjun Cheng 1, Ali G. Saad 1 and Lawrence M. Pfeffer 2,* 1 Department of Pathology, University of Tennessee Health Science Center, Memphis, TN 38163, USA; [email protected] (D.G.); [email protected] (C.C.); [email protected] (M.M.S.); [email protected] (C.H.Y.); [email protected] (M.T.); [email protected] (J.C.); [email protected] (A.G.S.) 2 Department of Pathology and the Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38163, USA * Correspondence: [email protected]; Tel.: +1-901-448-7855 Received: 18 February 2019; Accepted: 19 March 2019; Published: 26 March 2019 Abstract: Glioblastoma (GBM) is the most common and deadliest primary adult brain tumor. Invasion, resistance to therapy, and tumor recurrence in GBM can be attributed in part to brain tumor-initiating cells (BTICs). BTICs isolated from various patient-derived xenografts showed high expression of the poorly characterized Apelin early ligand A (APELA) gene. Although originally considered to be a non-coding gene, the APELA gene encodes a protein that binds to the Apelin receptor and promotes the growth of human embryonic stem cells and the formation of the embryonic vasculature. We found that both APELA mRNA and protein are expressed at high levels in a subset of brain tumor patients, and that APELA is also expressed in putative stem cell niche in GBM tumor tissue. Analysis of APELA and the Apelin receptor gene expression in brain tumor datasets showed that high APELA expression was associated with poor patient survival in both glioma and glioblastoma, and APELA expression correlated with glioma grade. In contrast, gene expression of the Apelin receptor or Apelin was not found to be associated with patient survival, or glioma grade. Consequently, APELA may play an important role in glioblastoma tumorigenesis and may be a future therapeutic target. Keywords: APELA; RNA-ISH; glioma; glioblastoma; cancer stem cells 1. Introduction Glioblastoma (GBM) is the most lethal intracranial neoplasm in adults and has a median survival of only 14–18 months [1]. Surgical resection combined with adjuvant chemotherapy and radiation therapy is the primary treatment of GBM, but has only provided slight improvement in the disease course and outcome for decades [2]. The cellular heterogeneity of GBM has been attributed to a subpopulation of brain tumor-initiating cells (BTICs), which express stem cell markers, can self-renew and undergo differentiation into multiple cell types [3–5]. BTICs have high tumor-initiating capacity and therapeutic resistance that can drive tumorigenesis and tumor recurrence after therapy [6]. We previously demonstrated that BTICs derived from patient-derived xenolines (PDXs) have markedly enhanced tumor-initiating activity when compared with BTICs induced to differentiate and form tumors that display identical histological features to the original PDX [7]. Apelin early ligand A (APELA), also called Elabela and Toddler, is an evolutionarily conserved peptide hormone that is essential for cardiovascular development in zebrafish through its binding to the G-protein coupled Apelin receptor (APLNR) [8]. APELA functions both as an endogenous ligand necessary for the growth of human embryonic stem cells [9] and in the formation of the embryonic vasculature [10]. Both Apelin and APELA bind to the Apelin receptor to transduce their distinct Pharmaceuticals 2019, 12, 45; doi:10.3390/ph12010045 www.mdpi.com/journal/pharmaceuticals Pharmaceuticals 2019, 12, x FOR PEER REVIEW 2 of 12 vasculature [10]. Both Apelin and APELA bind to the Apelin receptor to transduce their distinct biological functions [9]. While the Apelin/APLNR pathway is associated with fluid homeostasis, the neuroendocrine response to stress, and cardiovascular function [11], the biological function of the APELA/APLNR pathway is poorly understood. In the present study, we found that Apelin early ligand A (APELA) gene expression was markedly upregulated in BTICs isolated from a number of PDXs when compared with BTICs induced to differentiate. BTICs with high expression of the stem cell markers, Nestin and CD133, are localized near Pharmaceuticalscapillaries in2019 brain, 12, 45tumors, and this vascular niche is apparently critical for stem cell renewal2 [12]. of 11 Since APELA [10] and the Apelin receptor [13] have been shown to play important roles in vascular development and stem cell proliferation, we examined whether APELA and APLNR were expressed biological functions [9]. While the Apelin/APLNR pathway is associated with fluid homeostasis, in a stem cell niche in GBM patient tumor tissue by testing both RNA in situ hybridization (ISH) and the neuroendocrine response to stress, and cardiovascular function [11], the biological function of the immunohistochemistry (IHC), and found that APELA/APLNR-expressing cells were localized in a APELA/APLNR pathway is poorly understood. In the present study, we found that Apelin early putative stem cell niche. Analysis of brain tumor expression datasets showed that high APELA ligand A (APELA) gene expression was markedly upregulated in BTICs isolated from a number of expression was associated with poor patient survival. Our data suggest that APELA may play an PDXs when compared with BTICs induced to differentiate. important role in glioblastoma initiation and/or development, and could be a therapeutic target. BTICs with high expression of the stem cell markers, Nestin and CD133, are localized near capillaries in brain tumors, and this vascular niche is apparently critical for stem cell renewal [12]. 2. Results Since APELA [10] and the Apelin receptor [13] have been shown to play important roles in vascular development2.1. Identification and of stem APELA cell as proliferation, a Gene Overexpressed we examined in GBM whether and BTICs APELA and APLNR were expressed in a stem cell niche in GBM patient tumor tissue by testing both RNA in situ hybridization (ISH) and immunohistochemistryAPELA was originally identified (IHC), and as founda signaling that APELA/APLNR-expressingprotein in zebrafish embryos cellsby database were localized mining infor a non-annotated putative stem celltranslated niche. Analysisopen reading of brain frames tumor [14]. expression Subsequently, datasets APELA showed was thatfound high to promote APELA expressionboth the growth was associated of human with embryonic poor patient stem cells survival. and the Our formation data suggest of the that embryonic APELA may vasculature play an important[9,10]. To characterize role in glioblastoma the potential initiation importance and/or development,of APELA in stem-like and could cells be a in therapeutic GBM, we target.examined APELA expression by qPCR in BTICs isolated from different GBM PDXs (GBM6, GBMX10, and 2.GBMX16) Results and BTICs induced to differentiate. High APELA expression was found in BTICs isolated from various GBM PDXs as compared to BTICs induced to differentiate in the presence of serum 2.1.(Figure Identification 1A). Asof previously APELA as ashown Gene Overexpressed [15], serum-induced in GBM and differentiation BTICs of BTICs increased the expressionAPELA of was the originallyastrocyte marker identified glial as fibrillary a signaling acidic protein protein in zebrafish (GFAP) and embryos decreased by database the expression mining forof neural non-annotated stem cells translated markers, open including reading Nestin frames and [14 Sox2]. Subsequently,. In addition, APELA significantly was found higher to promote APELA bothexpression the growth was offound human in embryonicBTICs isolated stem from cells andthe thecentral formation region of of the a GBM embryonic tumor vasculature (BT238Z) [when9,10]. Tocompared characterize with theBTICs potential isolated importance from the tumor of APELA periphery in stem-like (BT238XY) cells (Figure in GBM, 1B). we examined APELA expressionBecause by APELA qPCR in was BTICs overexpressed isolated from in differentBTICs, APELA GBM PDXs expression (GBM6, was GBMX10, then determined and GBMX16) by qPCR and BTICsin RNA induced isolated to from differentiate. formalin-fixed High paraffin-emb APELA expressionedded (FFPE) was found biopsy in BTICsspecimens isolated obtained from from various the GBMUniversity PDXs of as Tennessee compared Health to BTICs Science induced Center to (UTHSC) differentiate tissue in services the presence core from of serumprimary (Figure low-grade1A). Asglioma previously (LGG) (World shown [Health15], serum-induced Organization differentiationclassification I and of BTICs II), GBM increased (World the Health expression Organization of the astrocyteclassification marker IV), glialand histologically fibrillary acidic benign protein brai (GFAP)n samples. and decreasedAlthough APELA the expression was expressed of neural at stemvery cellslow levels markers, in normal including brain Nestin samples, and Sox2statistically. In addition, significant significantly higher APELA higher expression APELA expression was found was in foundGBM inspecimens BTICs isolated (Figure from 1C), the which central appeared region of to a GBMreflect tumor a discrete (BT238Z) subset when of compared GBM patients with BTICs with isolatedmarkedly from higher the tumorAPELA periphery expression. (BT238XY) (Figure1B). Figure 1. APELA gene expression in brain tumor-initiating cells (BTICs), and in normal brain
Recommended publications
  • ELABELA, a Peptide Hormone for Heart Development
    RESEARCH HIGHLIGHTS parasites and confirmed its role in OXA resistance by showing that RNA The cancer epigenome of mice and men interference knockdown of Smp_089320 in drug-sensitive parasites Genetically engineered mouse models (GEMMs) of human resulted in an increase in resistance. They found that the Smp_089320 disease rarely take into account epigenetic alterations, which protein in sensitive but not resistant strains showed sulfonation activity, contribute to many human cancers. Now, Stephen Tapscott and identifying a mechanism for the drug in which it acts as a sulfotrans- colleagues compare genome-wide patterns of cancer-specific ferase that activates OXA. Finally, the authors determined the crystal DNA methylation in human patients and three GEMMs of structure of Smp_089320 protein from sensitive parasites with OXA medulloblastoma (Epigenetics 8, 1254–1260, 2013). Using two bound and suggest that the mechanism of resistance involves disruption independent methods to measure CpG methylation, they find, of the drug-protein interaction in resistant strains. Comparative and in contrast to the hypermethylation patterns previously observed phylogenetic analysis with other schistosomes also suggests the basis in patients with medulloblastoma, that GEMMs had only modest for the species specificity in OXA drug action. OB increase in CpG methylation of gene promoters relative to wild- type controls. Whereas a human medulloblastoma tumor sample showed >60% increase in methylation at 121 loci, consistent ELABELA, a peptide hormone for heart with the authors’ previous work, there were only 0–16 such loci development in the GEMMs. They further extend these findings to mouse models of Burkitt lymphoma and breast cancer, which showed Bruno Reversade and colleagues identify a highly conserved gene encod- similar results.
    [Show full text]
  • Computational Analysis Predicts Hundreds of Coding Lncrnas in Zebrafish
    biology Communication Computational Analysis Predicts Hundreds of Coding lncRNAs in Zebrafish Shital Kumar Mishra 1,2 and Han Wang 1,2,* 1 Center for Circadian Clocks, Soochow University, Suzhou 215123, China; [email protected] 2 School of Biology & Basic Medical Sciences, Medical College, Soochow University, Suzhou 215123, China * Correspondence: [email protected] or [email protected]; Tel.: +86-512-6588-2115 Simple Summary: Noncoding RNAs (ncRNAs) regulate a variety of fundamental life processes such as development, physiology, metabolism and circadian rhythmicity. RNA-sequencing (RNA- seq) technology has facilitated the sequencing of the whole transcriptome, thereby capturing and quantifying the dynamism of transcriptome-wide RNA expression profiles. However, much remains unrevealed in the huge noncoding RNA datasets that require further bioinformatic analysis. In this study, we applied six bioinformatic tools to investigate coding potentials of approximately 21,000 lncRNAs. A total of 313 lncRNAs are predicted to be coded by all the six tools. Our findings provide insights into the regulatory roles of lncRNAs and set the stage for the functional investigation of these lncRNAs and their encoded micropeptides. Abstract: Recent studies have demonstrated that numerous long noncoding RNAs (ncRNAs having more than 200 nucleotide base pairs (lncRNAs)) actually encode functional micropeptides, which likely represents the next regulatory biology frontier. Thus, identification of coding lncRNAs from ever-increasing lncRNA databases would be a bioinformatic challenge. Here we employed the Coding Potential Alignment Tool (CPAT), Coding Potential Calculator 2 (CPC2), LGC web server, Citation: Mishra, S.K.; Wang, H. Coding-Non-Coding Identifying Tool (CNIT), RNAsamba, and MicroPeptide identification tool Computational Analysis Predicts (MiPepid) to analyze approximately 21,000 zebrafish lncRNAs and computationally to identify Hundreds of Coding lncRNAs in 2730–6676 zebrafish lncRNAs with high coding potentials, including 313 coding lncRNAs predicted Zebrafish.
    [Show full text]
  • Endothelial Cell Dynamics in Vascular Development: Insights from Live-Imaging in Zebrafish
    fphys-11-00842 July 20, 2020 Time: 12:10 # 1 REVIEW published: 22 July 2020 doi: 10.3389/fphys.2020.00842 Endothelial Cell Dynamics in Vascular Development: Insights From Live-Imaging in Zebrafish Kazuhide S. Okuda1,2 and Benjamin M. Hogan1,2,3* 1 Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, 2 Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia, 3 Department of Anatomy and Neuroscience, University of Melbourne, Melbourne, VIC, Australia The formation of the vertebrate vasculature involves the acquisition of endothelial cell identities, sprouting, migration, remodeling and maturation of functional vessel networks. To understand the cellular and molecular processes that drive vascular development, live-imaging of dynamic cellular events in the zebrafish embryo have proven highly informative. This review focusses on recent advances, new tools and new insights from imaging studies in vascular cell biology using zebrafish as a model system. Keywords: vasculogenesis, angiogenesis, lymphangiogenesis, anastomosis, endothelial cell, zebrafish Edited by: INTRODUCTION Elizabeth Anne Vincent Jones, KU Leuven, Belgium Vascular development is an early and essential process in the formation of a viable vertebrate Reviewed by: embryo. Blood and lymphatic vascular networks are composed of a complex mix of cell types: for Anna Rita Cantelmo, example smooth muscle cells, fibroblasts, pericytes and immune cells are intimately associated and Université Lille Nord de France, even integrated within mature vessel walls (Rouget, 1873; Horstmann, 1952; Nicosia and Madri, France 1987; Fantin et al., 2010; Gordon et al., 2010). The inner lining of the vasculature, made up of Jingjing Zhang, endothelial cells (ECs), is the earliest part of the vasculature to develop in the embryo and is Affiliated Hospital of Guangdong Medical University, China instructive in recruiting other lineages and cell types as the vascular system matures.
    [Show full text]
  • ELABELA and an ELABELA Fragment Protect Against AKI
    BASIC RESEARCH www.jasn.org ELABELA and an ELABELA Fragment Protect against AKI † † ‡ Hong Chen,* Lin Wang, Wenjun Wang, Cheng Cheng,* Yu Zhang,* Yu Zhou, | † † Congyi Wang,§ Xiaoping Miao, Jiao Wang,* Chao Wang,* Jianshuang Li, Ling Zheng, and Kun Huang* *Tongji School of Pharmacy, §The Center for Biomedical Research, Tongji Hospital, and |School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; †Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China; and ‡Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri ABSTRACT Renal ischemia-reperfusion (I/R) injury is the most common cause of AKI, which associates with high mortality and has no effective therapy. ELABELA (ELA) is a newly identified 32-residue hormone pep- tide highly expressed in adult kidney. To investigate whether ELA has protective effects on renal I/R injury, we administered the mature peptide (ELA32) or the 11-residue furin-cleaved fragment (ELA11) to hypoxia-reperfusion (H/R)–injured or adriamycin-treated renal tubular cells in vitro.ELA32and ELA11 significantly inhibited the elevation of the DNA damage response, apoptosis, and inflammation in H/R-injured renal tubular cells and suppressed adriamycin-induced DNA damage response. Similarly, overexpression of ELA32 or ELA11 significantly inhibited H/R-induced cell death, DNA damage re- sponse, and inflammation. Notably, treatment of mice with ELA32 or ELA11 but not an ELA11 mutant with a cysteine to alanine substitution at the N terminus (AE11C) inhibited I/R injury-induced renal fibrosis, inflammation, apoptosis, and the DNA damage response and markedly reduced the renal tubular lesions and renal dysfunction.
    [Show full text]
  • Minireview: Novel Micropeptide Discovery by Proteomics and Deep Sequencing Methods
    fgene-12-651485 May 6, 2021 Time: 11:28 # 1 MINI REVIEW published: 06 May 2021 doi: 10.3389/fgene.2021.651485 Minireview: Novel Micropeptide Discovery by Proteomics and Deep Sequencing Methods Ravi Tharakan1* and Akira Sawa2,3 1 National Institute on Aging, National Institutes of Health, Baltimore, MD, United States, 2 Departments of Psychiatry, Neuroscience, Biomedical Engineering, and Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States, 3 Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States A novel class of small proteins, called micropeptides, has recently been discovered in the genome. These proteins, which have been found to play important roles in many physiological and cellular systems, are shorter than 100 amino acids and were overlooked during previous genome annotations. Discovery and characterization of more micropeptides has been ongoing, often using -omics methods such as proteomics, RNA sequencing, and ribosome profiling. In this review, we survey the recent advances in the micropeptides field and describe the methodological and Edited by: conceptual challenges facing future micropeptide endeavors. Liangliang Sun, Keywords: micropeptides, miniproteins, proteogenomics, sORF, ribosome profiling, proteomics, genomics, RNA Michigan State University, sequencing United States Reviewed by: Yanbao Yu, INTRODUCTION J. Craig Venter Institute (Rockville), United States The sequencing and publication of complete genomic sequences of many organisms have aided Hongqiang Qin, the medical sciences greatly, allowing advances in both human genetics and the biology of human Dalian Institute of Chemical Physics, Chinese Academy of Sciences, China disease, as well as a greater understanding of the biology of human pathogens (Firth and Lipkin, 2013).
    [Show full text]
  • Reduced ELABELA Expression Attenuates Trophoblast Invasion Through the PI3K/AKT/Mtor Pathway in Early Onset Preeclampsia T
    Placenta 87 (2019) 38–45 Contents lists available at ScienceDirect Placenta journal homepage: www.elsevier.com/locate/placenta Reduced ELABELA expression attenuates trophoblast invasion through the PI3K/AKT/mTOR pathway in early onset preeclampsia T Lijing Wanga,b, Yan Zhangc, Hongmei Qud, Fengsen Xub, Haiyan Hub, Qian Zhangb, ∗ Yuanhua Yea,c, a Department of Obstetrics and Gynecology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, 266000, China b Department of Obstetrics, Qingdao Municipal Hospital, Qingdao, 266000, China c Department of Obstetrics, Affiliated Hospital of Qingdao University, Qingdao, 266000, China d Department of Obstetrics, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, China ARTICLE INFO ABSTRACT Keywords: Introduction: Early onset preeclampsia is linked to abnormal trophoblast invasion, leading to insufficient re- ELA casting of uterine spiral arteries and shallow placental implantation. This study investigated ELABELA (ELA) PI3K expression and its involvement in the pathogenesis of early onset preeclampsia. AKT Methods: We used immunohistochemistry, quantitative PCR and Western blot to calculate ELA levels in the Invasion placentas. Transwell assays were utilize to assess the invasion and migration of trophoblastic Cells. Western blot Preeclampsia was used to identify the concentrations of vital kinases in PI3K/AKT/mTOR pathways and invasion-related proteins in trophoblast cells. Results: ELA was expressed in villous cytotrophoblasts and syncytiotrophoblasts in placental tissue. Compared with the normal pregnancies, ELA mRNA and protein expression was significantly reduced in early onset pre- eclampsia placentas. In the HTR-8/SVneo cells, when ELA was knocked down, the invasion and migration capability of cells decreased significantly, with MMP2 and MMP9 expression downregulated and the expression of important kinases in the PI3K/AKT/mTOR pathways being significantly decreased compared to the control group.
    [Show full text]
  • Scientific Release 6 December 2013 A*Star Scientists
    SCIENTIFIC RELEASE 6 DECEMBER 2013 A*STAR SCIENTISTS DISCOVER NOVEL HORMONE ESSENTIAL FOR HEART DEVELOPMENT This unusual discovery could aid cardiac repair and provide new therapies to common heart diseases and hypertension 1. Scientists at A*STAR’s Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids long, making it amongst the tiniest proteins made by the human body. 2. The team led by Dr Bruno Reversade carried out experiments to determine ELABELA’s function, since its existence was hitherto unsuspected. Using zebrafish designed to specifically lack this hormone, they uncovered that ELABELA is indispensable for heart formation. Zebrafish embryos without this gene had rudimentary or no heart at all (see Figure 1). Their results were published in the 5 December 2013 online issue of Developmental Cell. 3. Deficiencies in hormones are the cause of many diseases, such as the loss of insulin or insulin resistance, that results in diabetes, and irregularities in appetite and satiety hormones that can cause obesity. Hormones are known to control functions such as sleep, appetite and fertility. However, this is the first time that scientists have revealed the existence of a conserved1 hormone playing such an early role during embryogenesis, effectively orchestrating the development of an entire organ. 4. The team also found that ELABELA uses a receptor previously believed to be specific to APELIN, a blood-pressure controlling hormone.
    [Show full text]
  • Serum Elabela Level Significantly Increased in Patients with Complete Heart Block
    ORIGINAL ARTICLE Braz J Cardiovasc Surg 2020;35(5):683-8 Serum Elabela Level Significantly Increased in Patients with Complete Heart Block Armağan Acele1, MD; Atilla Bulut1, MD; Yurdaer Donmez1, MD; Mevlut Koc1, MD DOI: 10.21470/1678-9741-2019-0461 Abstract Objective: To investigate the change in serum Elabela level, (NT-proBNP) levels, but negatively correlated with heart rate, a new apelinergic system peptide, in patients with complete high-density lipoprotein cholesterol, and cardiac output. In linear atrioventricular (AV) block and healthy controls. regression analysis, it was found that these parameters were only Methods: The study included 50 patients with planned cardiac closely related to heart rate and NT-proBNP. Serum Elabela level pacemaker (PM) implantation due to complete AV block and 50 was determined in the patients with AV block independently; healthy controls with similar age and gender. Elabela level was an Elabela level > 9.5 ng/ml determined the risk of complete AV- measured in addition to routine anamnesis, physical examination, block with 90.2% sensitivity and 88.0% specificity. and laboratory tests. Patients were divided into two groups, with Conclusion: In patients with complete AV block, the serum and without AV block, and then compared. Elabela level increases significantly before the PM implantation Results: In patients with AV block, serum Elabela level was procedure. According to the results of our study, it was concluded significantly higher and heart rate and cardiac output were that serum Elabela level could be used in the early determination significantly lower than in healthy controls. Serum Elabela of patients with complete AV block.
    [Show full text]
  • Is ELABELA a Reliable Biomarker for Hypertensive Disorders of Pregnancy?
    Pregnancy Hypertension 17 (2019) 226–232 Contents lists available at ScienceDirect Pregnancy Hypertension journal homepage: www.elsevier.com/locate/preghy Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy? T Rong Huanga,1, Jing Zhua,b,1, Lin Zhangb, Xiaolin Huab, Weiping Yeb, Chang Chena,c, Kun Sund, ⁎ ⁎ Weiye Wanga, Liping Fenga,e, , Jun Zhanga,c, , for the Shanghai Birth Cohort study a Ministry of Education-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai 200092, China b Department of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China c School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China d Department of Pediatric Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, China e Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC 27710, USA ARTICLE INFO ABSTRACT Keywords: Objective: We aimed to examine the ELABELA levels at different stages of pregnancy among normotensive ELABELA controls and women with hypertensive disorders of pregnancy (HDP). Hypertensive disorders of pregnancy Study design: A total of 336 blood samples of 169 women were collected from pre-pregnancy, the first, second, Biomarker and third trimesters. Women were divided into the following six groups: 1) non-pregnant healthy women; 2) healthy pregnant controls; 3) chronic hypertension; 4) gestational hypertension; 5) preeclampsia; and 6) pre- eclampsia superimposed on chronic hypertension. ELABELA plasma concentrations were measured by human ELA Elisa Kit (Peninsula Laboratories International, Inc. USA). Kruskal-Wallis test was used to test whether ELABELA level in each type of HDP differed from that in gestational week-matched normotensive controls.
    [Show full text]
  • Identification of Rhythmically Expressed Lncrnas in the Zebrafish Pineal Gland and Testis
    International Journal of Molecular Sciences Article Identification of Rhythmically Expressed LncRNAs in the Zebrafish Pineal Gland and Testis Shital Kumar Mishra 1,2, Taole Liu 1,2 and Han Wang 1,2,* 1 Center for Circadian Clocks, Soochow University, Suzhou 215123, China; [email protected] (S.K.M.); [email protected] (T.L.) 2 School of Biology & Basic Medical Sciences, Medical College, Soochow University, Suzhou 215123, China * Correspondence: [email protected] or [email protected]; Tel.: +86-51265882115 Abstract: Noncoding RNAs have been known to contribute to a variety of fundamental life processes, such as development, metabolism, and circadian rhythms. However, much remains unrevealed in the huge noncoding RNA datasets, which require further bioinformatic analysis and experimental investigation—and in particular, the coding potential of lncRNAs and the functions of lncRNA- encoded peptides have not been comprehensively studied to date. Through integrating the time- course experimentation with state-of-the-art computational techniques, we studied tens of thousands of zebrafish lncRNAs from our own experiments and from a published study including time-series transcriptome analyses of the testis and the pineal gland. Rhythmicity analysis of these data revealed approximately 700 rhythmically expressed lncRNAs from the pineal gland and the testis, and their GO, COG, and KEGG pathway functions were analyzed. Comparative and conservative analyses determined 14 rhythmically expressed lncRNAs shared between both the pineal gland and the testis, and 15 pineal gland lncRNAs as well as 3 testis lncRNAs conserved among zebrafish, mice, and humans. Further, we computationally analyzed the conserved lncRNA-encoded peptides, and revealed three pineal gland and one testis lncRNA-encoded peptides conserved among these three Citation: Mishra, S.K.; Liu, T.; Wang, species, which were further investigated for their three-dimensional (3D) structures and potential H.
    [Show full text]
  • Peptide Hormone ELABELA Enhances Extravillous Trophoblast
    www.nature.com/scientificreports OPEN Peptide hormone ELABELA enhances extravillous trophoblast diferentiation, but placenta is not the major source of circulating ELABELA in pregnancy Danai Georgiadou1, Souad Boussata1, Willemijn H. M. Ranzijn1, Leah E. A. Root1, Sanne Hillenius1, Jeske M. bij de Weg2, Carolien N. H. Abheiden2, Marjon A. de Boer2, Johanna I. P. de Vries2, Tanja G. M. Vrijkotte3, Cornelis B. Lambalk4, Esther A. M. Kuijper4, Gijs B. Afnk1 & Marie van Dijk1* Preeclampsia is a frequent gestational hypertensive disorder with equivocal pathophysiology. Knockout of peptide hormone ELABELA (ELA) has been shown to cause preeclampsia-like symptoms in mice. However, the role of ELA in human placentation and whether ELA is involved in the development of preeclampsia in humans is not yet known. In this study, we show that exogenous administration of ELA peptide is able to increase invasiveness of extravillous trophoblasts in vitro, is able to change outgrowth morphology and reduce trophoblast proliferation ex vivo, and that these efects are, at least in part, independent of signaling through the Apelin Receptor (APLNR). Moreover, we show that circulating levels of ELA are highly variable between women, correlate with BMI, but are signifcantly reduced in frst trimester plasma of women with a healthy BMI later developing preeclampsia. We conclude that the large variability and BMI dependence of ELA levels in circulation make this peptide an unlikely candidate to function as a frst trimester preeclampsia screening biomarker, while in the future administering ELA or a derivative might be considered as a potential preeclampsia treatment option as ELA is able to drive extravillous trophoblast diferentiation.
    [Show full text]
  • ELABELA Ameliorates Hypoxic/Ischemic-Induced Bone
    Fu et al. Stem Cell Research & Therapy (2020) 11:541 https://doi.org/10.1186/s13287-020-02063-1 RESEARCH Open Access ELABELA ameliorates hypoxic/ischemic- induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K/AKT and ERK1/2 pathways Jiaying Fu1,2†, Xuxiang Chen1†, Xin Liu1,2†, Daishi Xu1, Huan Yang1, Chaotao Zeng2, Huibao Long2, Changqing Zhou1, Haidong Wu1, Guanghui Zheng2, Hao Wu2, Wuming Wang1 and Tong Wang1* Abstract Background: Mesenchymal stem cells (MSCs) have exerted their brilliant potential to promote heart repair following myocardial infarction. However, low survival rate of MSCs after transplantation due to harsh conditions with hypoxic and ischemic stress limits their therapeutic efficiency in treating cardiac dysfunction. ELABELA (ELA) serves as a peptide hormone which has been proved to facilitate cell growth, survival, and pluripotency in human embryonic stem cells. Although ELA works as an endogenous ligand of a G protein-coupled receptor APJ (Apelin receptor, APLNR), whether APJ is an essential signal for the function of ELA remains elusive. The effect of ELA on apoptosis of MSCs is still vague. Objective: We studied the role of ELABELA (ELA) treatment on the anti-apoptosis of MSCs in hypoxic/ischemic (H/I) conditions which mimic the impaired myocardial microenvironment and explored the possible mechanisms in vitro. Methods: MSCs were obtained from donated rats weighing between 80~120 g. MSCs were exposed to serum-free and hypoxic (1% O2) environments for 24 h, which mimics hypoxic/ischemic damage in vivo, using serum- containing normoxic conditions (20% O2) as a negative control.
    [Show full text]